Ann: DurAVR FIH 30-Day Study Results Presented at TCT Boston, page-9

Its now 4 weeks post the 12month mark so we should expect an announcement very soon. Given this concludes the formal part of the study maybe there is more emphasis put into the documentation for this part of the study.

Also they may have to fly their own team over to Europe for this. Given the London valves conference fell around the same time maybe they waited to after its conclusion to commence following up the 12 month studies.

Another guess maybe they are linking the 12month results with another strategic announcement. Funding partnership or similar that gives us a clear roadmap for the forthcoming FDA studies.

All IMO.